MND

What are patients’ priorities for MND research? 1:29
What are patients’ priorities for MND research?
Jane Haley • 24 Apr 2023
Addressing unmet needs in MND care 1:59
Addressing unmet needs in MND care
Jane Haley • 24 Apr 2023
Putting the MND community at the heart of MND Scotland’s research strategy 3:23
Putting the MND community at the heart of MND Scotland’s research strategy
Jane Haley • 24 Apr 2023
MND-SMART: the adaptive platform trial investigating potential treatments for MND 3:22
MND-SMART: the adaptive platform trial investigating potential treatments for MND
Jane Haley • 24 Apr 2023
The MND Scotland strategy: making time count 2:18
The MND Scotland strategy: making time count
Jane Haley • 24 Apr 2023
Developing antibodies against pathogenic TDP-43 in ALS 3:42
Developing antibodies against pathogenic TDP-43 in ALS
Johanne Kaplan • 30 Mar 2023
Important developments in understanding the mechanisms of ALS 1:47
Important developments in understanding the mechanisms of ALS
Matthew Kiernan • 4 Apr 2022
Changing our approach to ALS clinical trial design 3:44
Changing our approach to ALS clinical trial design
Nigel Leigh • 17 Mar 2022
Developing biomarker panels for ALS diagnosis 2:53
Developing biomarker panels for ALS diagnosis
Nigel Leigh • 17 Mar 2022
MIROCALS: low-dosage IL-2 for the treatment of ALS 2:13
MIROCALS: low-dosage IL-2 for the treatment of ALS
Nigel Leigh • 17 Mar 2022
Improving ALS diagnosis: the Gold Coast criteria and the role of TMS 2:44
Improving ALS diagnosis: the Gold Coast criteria and the role of TMS
Matthew Kiernan • 4 Apr 2022
The content of VJNeurology is intended for healthcare professionals